Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

Politicians are once again fighting over public classrooms. The latest battle centers on a 40-year-old U.S. Supreme Court ...

The movement-related benefits of Itvisma were maintained or continued to deepen over about 15 months after treatment, trial results show.

Crispr Therapeutics Ag (NASDAQ:CRSP) is one of the Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. Biotech company Crispr ...

Researchers have revealed how bacteria precisely control the genes that trigger cell division. The study shows that the MraZ protein, which normally forms a donut-shaped structure, must bend and ...

Sickle cell disease—the subject of a new Seminar in The Lancet—is one of the most prevalent and fastest-growing genetic disorders worldwide. Although its true prevalence is difficult to determine ...

A new synthesis finds that common epilepsies are driven by thousands of tiny-effect genetic variants, most still ...

Favorable early safety and initial efficacy data from BEST1 program highlighted at premier gathering of global retinal experts with additional ...

The Lord called Eugene Thompson home on March 2, 2026; he was 89 years old. Born on August 17, 1936, on his grandparents’ farm in Randolph County, Indiana, to Nolan C. and S. Pearl (Eads) Thompson; he ...

To model bacterial life, Thornburg and his colleagues turned to one of its simplest examples: a bacterial cell with a ...

Purdue University researcher Emily Dykhuizen explores how cancer takes advantage of the machinery that surrounds DNA, enabling some of its most pernicious powers, like the ability to evade the immune ...

Researchers have discovered that mutations in the FOXJ3 gene act as a "master switch" failure, disrupting how the brain builds its layers and leading to FCD, a primary cause of drug-resistant epilepsy ...